BSEGKB Ophthalmics LtdLowNeutral
Announced Thu, 2 Apr · 15:41 IST

Please find enclosed herewith the disclosure under Regulation 31 (4) of Securities and Exchange Board of India ( Substantial Acquisition of Shares and Takeover ) Regulation 2011 for the ....

Ownership Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-6.6%1-day move
₹57.40
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-6.6+12.2+27.7+29.5+27.2+21.6+17.0+11.9+4.5+5.1
Up moveDown movePending
AI summary

GKB Ophthalmics Ltd has submitted a Regulation 31(4) disclosure to BSE, confirming that the Promoter group (led by Mr. Krishna Gopal Gupta) has not made any share encumbrance — directly or indirectly — during the financial year ended March 31, 2026. The filing is a standard compliance confirmation submitted by the Company Secretary on behalf of the promoters. This is a nil-report, meaning no pledge or encumbrance was created on promoter shares during the period.

Likely market impact

The confirmation of zero share encumbrance is a positive signal for investors, indicating no pressure on promoter holdings from pledged shares. It reduces concerns about potential stake dilution or forced selling.